Experts met 24th-25th May in Maastricht, The Netherlands, to discuss the latest news about PCSK9 science and research. The third in this series of presentations focuses on triglyceride-rich lipoproteins, driven by emerging evidence that PCSK9 might play a role in the modulation of their metabolism.

Professor Erik Stroes (Amsterdam Medical Center, The Netherlands): New approaches to managing moderate hypertriglyceridaemia

Listen to the presentation here »

Professor Jan Boren (Sahlgrenska Academy, University of Gothenburg, Sweden): Hepatic lipid metabolism: Comparing effects on storage vs. secretion

Listen to the presentation here »

Professor Brian Ference (University of Cambridge, UK): Why naturally randomized genetic studies provide important evidence for estimating the clinical benefit from lowering triglyceride-rich lipoproteins

Listen to the presentation here »

Education: the primary mission of PCSK9 Forum.

Don’t forget to check back for the latest updates to the PCSK9 Forum educational slide resource programme